Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001008161-13-000002

Options or other derivatives

  • CEO acquired 500,000 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
CARTER WILLIAM A CEO 2013-06-06 Other acquisition · Options to buy Common Stock +500,000 7,865,378 D
Loading xslF345X03/primary_doc.xml…